Drug CarriersAntineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsDrug Delivery SystemsEmployer Health CostsDoxorubicinCisplatinChemotherapy, AdjuvantCell Line, TumorDrug Resistance, NeoplasmEtoposideNeoplasmsPrescription FeesNanoparticlesAntineoplastic Agents, PhytogenicPaclitaxelCell SurvivalDrug Screening Assays, AntitumorBreast NeoplasmsParticle SizeApoptosisCombined Modality TherapyOvarian NeoplasmsFluorouracilChitosanLiposomesChemistry, PharmaceuticalPolyethylene GlycolsCyclophosphamideCarrier StateDose-Response Relationship, DrugNanocapsulesTreatment OutcomeTechnology, PharmaceuticalFractionation, Field FlowNanomedicineAconitic AcidDrug CompoundingTumor Cells, CulturedPolymersDendrimersCellulose, OxidizedPolyglactin 910Neoadjuvant TherapyDisease-Free SurvivalCell ProliferationPoloxamerGene Expression Regulation, NeoplasticEmulsionsAntibiotics, AntineoplasticDelayed-Action PreparationsNeoplasm StagingSurvival AnalysisNanotechnologyTissue DistributionMicellesPrognosisSurvival RateLung NeoplasmsMethotrexateDrug Administration ScheduleNanostructuresSolubilityPolyestersCarboplatinCapsulesCarrier ProteinsVinblastineInduction ChemotherapyMicrospheresAcrylamidesNeoplasm Recurrence, LocalTaxoidsPoly IPowder DiffractionAcyl Carrier ProteinPolyglycolic AcidIfosfamideTime FactorsSurface-Active AgentsHeterozygote DetectionBleomycinAntimetabolites, AntineoplasticOrganoplatinum CompoundsCalorimetry, Differential ScanningDeoxycytidinePowdersFollow-Up StudiesHeterozygoteAnthracyclinesAntineoplastic Agents, AlkylatingMagneticsSurface PropertiesBiocompatible MaterialsCytarabineChemotherapy, Cancer, Regional PerfusionExcipientsCarcinoma, Non-Small-Cell LungSalvage TherapyReduced Folate Carrier Protein